Aclaris therapeutics to participate in upcoming investor conferences

Wayne, pa., nov. 03, 2021 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that management will participate in the following upcoming investor conferences:

ACRS Ratings Summary

ACRS Quant Ranking